What is Bicara Therapeutics Inc. Common Stock's Market Cap?

Bicara Therapeutics Inc. Common Stock's Market Cap is $1.6B, based on as-reported figures from SEC (XBRL) filings.

What is Bicara Therapeutics Inc. Common Stock's Enterprise Value?

Bicara Therapeutics Inc. Common Stock's Enterprise Value is $1.1B, based on as-reported figures from SEC (XBRL) filings.

What is Bicara Therapeutics Inc. Common Stock's EV / EBITDA?

Bicara Therapeutics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Bicara Therapeutics Inc. Common Stock's Net Income (TTM)?

Bicara Therapeutics Inc. Common Stock's Net Income (TTM) is -$185.4M, based on as-reported figures from SEC (XBRL) filings.

What is Bicara Therapeutics Inc. Common Stock's EBITDA?

Bicara Therapeutics Inc. Common Stock's EBITDA is -$201.8M, based on as-reported figures from SEC (XBRL) filings.

What is Bicara Therapeutics Inc. Common Stock's Diluted EPS (TTM)?

Bicara Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -2.80, based on as-reported figures from SEC (XBRL) filings.

What is Bicara Therapeutics Inc. Common Stock's Net Debt?

Bicara Therapeutics Inc. Common Stock's Net Debt is -$497.3M, based on as-reported figures from SEC (XBRL) filings.

Bicara Therapeutics Inc. Common Stock (BCAX) Financial Statements

Bicara Therapeutics Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00Z15DGL6

XNAS · usd

23.71▲ 0.54 (2.33%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close23.17

Day's Range22.26 – 23.98

52-Week Range10.30 – 30.99

Volume708.0K

Avg Volume605.5K

Share Statistics

Shares Outstanding

Employees103

ExchangeXNAS

Listed2024-09-13

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Bicara Therapeutics Inc. Common Stock (BCAX)

What is Bicara Therapeutics Inc. Common Stock's Market Cap?: Bicara Therapeutics Inc. Common Stock's Market Cap is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Bicara Therapeutics Inc. Common Stock's Enterprise Value?: Bicara Therapeutics Inc. Common Stock's Enterprise Value is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Bicara Therapeutics Inc. Common Stock's EV / EBITDA?: Bicara Therapeutics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Bicara Therapeutics Inc. Common Stock's Net Income (TTM)?: Bicara Therapeutics Inc. Common Stock's Net Income (TTM) is -$185.4M, based on as-reported figures from SEC (XBRL) filings.
What is Bicara Therapeutics Inc. Common Stock's EBITDA?: Bicara Therapeutics Inc. Common Stock's EBITDA is -$201.8M, based on as-reported figures from SEC (XBRL) filings.
What is Bicara Therapeutics Inc. Common Stock's Diluted EPS (TTM)?: Bicara Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -2.80, based on as-reported figures from SEC (XBRL) filings.
What is Bicara Therapeutics Inc. Common Stock's Net Debt?: Bicara Therapeutics Inc. Common Stock's Net Debt is -$497.3M, based on as-reported figures from SEC (XBRL) filings.